What a different world is possible," said Vernice Ferguson, RN, MA, FAAN, FRCN, accepting the Distinguished Merit Award at the opening session of the 16th International Conference on Cancer Nursing in Atlanta, Georgia. She spoke of the importance of preventive medicine and the critical role nurses play in promoting healthy lifestyles, which she said could prevent the occurrence of up to one third of all cancers.
For patients with relapsed or refractory multiple myeloma (MM), bortezomib-based therapy is effective after lenalidomide plus dexamethasone (LD), according to a Canadian study that evaluated sequencing of novel agents presented at the 51st Annual Meeting and Exposition of the American Society of Hematology.
One third of patients with newly diagnosed, advanced chronic lymphocytic leukemia (CLL) who received the combination of bendamustine and rituximab achieved a complete response, according to researchers from the German CLL Study Group.
To sign up for our newsletter or print publications, please enter your contact information below.
